Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag in chemotherapy-induced thrombocytopenia
NCT00102726Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of eltrombopag in Thrombocytopenia, sponsored by GSK. Started Feb 2005; status: completed.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00102726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102726.